Pramila Rani Anne, MD - Jefferson University Hospitals

Pramila Rani Anne MD

Academic Title

Associate Professor

Specialties

Radiation Oncology
Radiation Oncology - Breast Cancer
Radiation Oncology - Colorectal Cancer
Radiation Oncology - Esophageal Cancer
Radiation Oncology - Gastrointestinal (GI) Cancer
Radiation Oncology - Gynecologic Cancer
Radiation Oncology - Head & Neck Cancer
Radiation Oncology - Liver Cancer
Radiation Oncology - Melanoma/Skin Cancer
Radiation Oncology - Pancreatic Cancer
Radiation Oncology - Soft Tissue Sarcoma
Radiation Oncology - Stomach Cancer

Book an Appointment

If you have a Jefferson Health MyChart account you can directly schedule within MyChart.

Contact Us

New or returning patients can complete our secure, online appointment request form. A representative from Jefferson will contact you by email to confirm your appointment.

Request an Appointment

If you'd rather speak with a JEFF NOW® representative, click 1-800-JEFFNOW below. You will then be prompted to enter your phone number.

Call 1-800-JEFFNOW

Overview

Locations

Departments & Programs

Conditions

Treatments

Tests

Biopsy

Education & Fellowships

University of Virginia, Medical School
Internship: Riverside Regional Medical Center
Residency: Massachusetts General Hospital Harvard University, Boston, MA

Years in Practice

Board Certification

Radiation Oncology

Hospital Affiliation

Thomas Jefferson University Hospital

Insurances Accepted

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Aetna
Aetna PA Employee Benefit Trust Fund (PEBTF)
AmeriHealth
AmeriHealth HMO
AmeriHealth Personal Choice
Amerihealth 65
Amerihealth Caritas
BC BS Special Care
Blue Cross/Blue Shield
Cigna Healthspring
Cigna PPO, POS
Consumer Health Network PPO
CorVel
Coventry/Health America
Devon
Employers Health Network PPO
Evolutions (Guardian Resources)
Federal BCBS
First Health Network
Fortified Provider Network
Galaxy
Geisinger Health Plan
Health America PPO
Health Management Network PPO
Horizon Blue Cross/Blue Shield
Horizon HMO
HumanaChoicePPO,Medicare,GoldPlusHMO
Intergroup Preferred
Keystone 65 HMO
Keystone First VIP Choice
Keystone First/Connect
Keystone Health Plan East
Medicaid of PA
Medicare
Mercy LIFE
MultiPlan Inc.
NJ Blue Shield
One Net PPO
PPO Next
Personal Choice (GPPPN)
Personal Choice 65
PlanCare America
Preferred Care PPO
Prime Health Services, Inc.
Private Healthcare Systems (PHCS)
Provider Select Inc
Qualcare
Tricare
UPMC HMO,PPO ReadingHspEmpONLY
UPMC Medicare HMO
US Family Health Plan
United Healthcare

Patient Ratings

Friendliness/courtesy of the care provider:

Explanations the care provider gave you about your problem or condition:

Concern the care provider showed for your questions or worries:

Care provider's efforts to include you in decisions about your treatment:

Instructions the care provider gave you about follow-up care (if any):

Degree to which care provider talked with you using words you could understand:

Amount of time the care provider spent with you:

Your confidence in this care provider:

Likelihood of your recommending this care provider to others:

Overall Rating:

Learn more about Patient Ratings

Awards

Philadelphia Magazine's Top Docs 2018, 2016

Publications

Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer

Phase i Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib with Concurrent Radiotherapy for Advanced Head and Neck Cancer

Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics

Eastern cooperative oncology group and american college of radiology imaging network randomized phase 2 trial of neoadjuvant preoperative paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design

Yttrium-90 microsphere brachytherapy for liver metastases from uveal melanoma clinical outcomes and the predictive value of fluorodeoxyglucose positron emission tomography

Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold

Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial

NRG oncology radiation therapy oncology group 0822: A phase 2 study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Efficacy endpoints of radiation therapy group protocol 0247: A randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Radiation therapy use and outcomes among older women with ER-Positive and ER-negative stage I breast cancer

Conditional survival probabilities for patients with resected pancreatic adenocarcinoma

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer

Impact of a radiation oncology elective on the careers of young physicians: Update on a prospective cohort study

Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer

Head and neck carcinoma in the United States: First comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)

Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies

Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school

Radiation therapy in breast-conserving therapy for invasive breast cancer

Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer

Implementation and experimental results of 4D tumor tracking using robotic couch

Contact Us

New or returning patients can complete our secure, online appointment request form. A representative from Jefferson will contact you by email to confirm your appointment.

Request an Appointment

If you'd rather speak with a JEFF NOW® representative, click 1-800-JEFFNOW below. You will then be prompted to enter your phone number.

Call 1-800-JEFFNOW

Primary Location

111 South 11th Street
Suite G-301, Bodine Center
Philadelphia, PA 19107

Phone: (215) 955-6702
Fax: (215) 955-0412

Get Directions